1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Russia Pharmaceuticals and Healthcare Report Q2 2016

Russia Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 86 pages

Includes 3 FREE quarterly updates

BMI View: Russia's healthcare market is in a precarious position due to a severe lack of funding and anescalating burden of disease. The country's economic recession will see further pressure placed on thepopulation for provision of care. Amendments to Russia's pharmaceutical legislation will, however, favourdomestically-produced medicines over foreign drugmakers and multinational drugmakers will be pressuredto establish a domestic manufacturing presence to comply to related new regulations. Nonetheless, given itssheer market size and unmet potential, the country will remain attractive for investment by multinationalpharmaceutical firms for long-term growth.Headli

ne Expenditure Projections

- Pharmaceuticals: RUB1.02trn (USD16.58bn) in 2015 to RUB1.15trn (USD15.42bn) in 2016; +12.7% inlocal currency terms and -7.0% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: RUB5.29trn (USD86.31bn) in 2015 to RUB5.75trn (USD77.30bn) in 2016; +8.6% in localcurrency terms and -10.4% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Russia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Russia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index 29
Russia Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 40
Pricing Regime 42
Reimbursement Regime 46
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Russia 2010-2015) 49
Table: Healthcare Personnel (Russia 2010-2015) 49
Table: Healthcare Activity (Russia 2010-2015) 50
Research and Development 50
Clinical Trials 51
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 58
Generic Drugmakers 59
Pharmaceutical Retail Sector 60
Company Profile 62
Johnson and Johnson 62
Novartis 65
Pharmstandard 69
Veropharm 73
Demographic Forecast 75
Demographic Outlook 75
Table: Population Headline Indicators (Russia 1990-2025) 76
Table: Key Population Ratios (Russia 1990-2025) 76
Table: Urban/Rural Population and Life Expectancy (Russia 1990-2025) 77
Table: Population By Age Group (Russia 1990-2025) 77
Table: Population By Age Group % (Russia 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.